Lantern Pharma Inc.
Lantern Pharma develops oncology therapeutics guided by its RADR artificial intelligence platform for patient selection and biomarker-driven development.
8-KNov 18Latest SEC filing
Nov 18Latest story
Lantern Pharma develops oncology therapeutics guided by its RADR artificial intelligence platform for patient selection and biomarker-driven development.
November 2026
September 2026
August 2026